The authors have identified testing strategies to ensure the immunogenic safety of Helaina rhLF (EfferaTM) that were vetted by experts in the field of immunology/allergy, immunotoxicology, lactoferrin biology and nutrition, and food safety assessment, the details of which were recently published (50). The gene discussed is LTF; the disease is allergic disease.